论文信息 - First-in-human phase 1/1b expansion of PMD-026, an oral RSK inhibitor, in patients with metastatic triple-negative breast cancer. - 字舞流文

First-in-human phase 1/1b expansion of PMD-026, an oral RSK inhibitor, in patients with metastatic triple-negative breast cancer.

M. Beeram | A. Patnaik | S. Dunn | A. Dorr | S. Hurvitz | G. Los | Judy S. Wang | P. Chalasani | R. Wesolowski | M. Trivedi | My-my Huynh | M. Pambid | Aarthi Jayanthan | R. Shatsky | L. Mina | H. Han